Eli Lilly signs $2.3b AI biotech deal with Profluent
Lilly has signed at least 15 AI deals in the past five years, boosting its AI drug discovery efforts.
ORIGINAL SOURCE →via Tech in Asia
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · tech
- [TECH] New tech, new rules: Narrative and civil society in the age of AI and algorithms
- [TECH] Product Hunt Launch Complete Guide — Indie Dev Strategy for Day-1 Top 10
- [TECH] GitHub 星标 18.6 万的工具，90% 的团队用错了：n8n 工作流的 5 个隐藏神技 🔥
- [TECH] n8n's 5 Hidden Workflow Patterns Nobody Teaches (186K Stars, But 90% Use It Wrong)
- [TECH] Idea for Managing Policies Across Nearly 1,000 AWS Organizations — A Reseller's Perspective
- [TECH] Cold Starts Are Dead